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S-thanatin (Ts) was a short antimicrobial peptide with selective antibacterial activity. In
this study, we aimed to design a drug carrier with specific bacterial targeting potential.
The positively charged Ts was modified onto the liposome surface by linking Ts to
the constituent lipids via a PEG linker. The benefits of this design were evaluated by
preparing a series of liposomes and comparing their biological effects in vitro and in vivo.
The particle size and Zeta potential of the constructed liposomes were measured with
a Zetasizer Nano ZS system and a confocal laser scanning microscope. The in vitro
drug delivery potential was evaluated by measuring the cellular uptake of encapsulated
levofloxacin using HPLC. Ts-linked liposome or its conjugates with quantum dots
favored bacterial cells, and increased the bacterial uptake of levofloxacin. In antimicrobial
assays, the Ts and levofloxacin combination showed a synergistic effect, and Ts-LPs-
LEV exhibited excellent activity against the quality control stain Klebsiella pneumoniae
ATCC 700603 and restored the susceptibility of multidrug-resistant K. pneumoniae
clinical isolates to levofloxacin in vitro. Furthermore, Ts-LPs-LEV markedly reduced the
lethality rate of the septic shock and resulted in rapid bacterial clearance in mouse
models receiving clinical multidrug resistant (MDR) isolates. These results suggest that
the Ts-functionalized liposome may be a promising antibiotic delivery system for clinical
infectious disorders caused by MDR bacteria, in particular the sepsis related diseases.
Keywords: targeting delivery, sepsis, antimicrobial peptide, liposome, multidrug resistance
INTRODUCTION
Increasing data from clinics has revealed the wide spreading of multidrug resistant (MDR)
Klebsiella pneumoniae resistant to almost all conventional antibiotics with diﬀerent structures,
such as cephalosporins, carbapenems, ﬂuoroquinolones, lincosamides, and aminoglycosides (Datta
et al., 2012; Leone et al., 2012; Kronman et al., 2014). Developing antibiotics with new antimicrobial
mechanisms has again become a matter of emergency (Bassetti and Righi, 2015).
Antimicrobial peptides (AMPs) exhibit a broad antimicrobial activity independent of current
drug resistance (da Costa et al., 2015). AMPs are considered as a promising solution for the
drug resistance and are expected to reach a good synergistic eﬀect when in combination with the
traditional antibiotics due to their unique antimicrobial mechanism. In our previous study, we
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reported a novel antimicrobial peptide of S-thanatin that
exhibited selective antimicrobial activity (Wu et al., 2010a,b;
Bassetti and Righi, 2015). Notably, Ts showed lipopolysaccharide
(LPS) binding aﬃnity, indicating its great potential as a treatment
for blood infections (Wu et al., 2010a,b). Ts was proved active
against numerous Gram-negative bacteria including MDR but
barely active over the Gram-positive species (Wu et al., 2011).
The antimicrobial activity of Ts is structure dependent. Ts is
a random coil with limited or none antimicrobial activity but
adopts a beta-sheet form after activation (Wu et al., 2010a,b).
Ts kills bacteria in a membrane-dependent manner. Negatively
charged components such as LPS on the cell wall of Gram-
negative bacteria and negatively charged lipids on bacterial
cytoplastic membranes, can attract Ts electrostatically and thus
promote the intercalation of Ts into the cytoplastic membrane.
The cytoplastic membrane becomes leaky, which subsequently
disintegrates the bacterial respiration and energization (Wu et al.,
2010b).
Liposomes have been widely used as pharmaceutical carriers
in the past decade due to their merits, such as reducing potential
toxicity, prolonging circulation half-life in vivo, and enabling
controlled release and active or passive targeting of speciﬁc
cells, tissues, or organs (Kibria et al., 2013). Liposomes have
been reported to serve as carriers for antibiotics (Furneri et al.,
2000; Muppidi et al., 2011), improving the pharmacokinetics
of the encapsulated antibiotics. However, to the best of our
knowledge, the coupling of AMPs, such as Ts, to an antibiotic-
loaded liposome and the application on bacterial cells have not
been reported.
The Ts functioned liposomes were prepared by linking the Ts
to the constituent lipids with a PEG linker. Ts played dual-role in
this design as a targeting carrier and a bactericidin as well. The
preparations were tested in vitro and in vivo for antimicrobial
activities against clinical MDR isolates.
MATERIALS AND METHODS
Chemical Reagents
Hydrogenated soybean phosphatidylcholine (HSPC), cholesterol
(CHO), and 3-(N-succinimidyloxyglutaryl) aminopropyl-
polyethyleneglycol (2000)-carbamyldistearoyl phosphatidyl
ethanolamine (NHS-PEG2000-DSPE) were purchased from
Avanti Polar Lipids (Alabaster, AL, USA). The antimicrobial
peptide Ts (GSKKPVPIIYCNRRSGKCQRM) was synthesized,
refolded and puriﬁed, as previously reported (Wu et al., 2010a,b).
Ts was conjugated with NHS-PEG2000-DSPE using a method
similar to the synthesis of RGD (arginine-glycine-aspartic
acid) peptide conjugation (Kibria et al., 2013). Brieﬂy, the
Ts peptide was coupled with NHS-PEG-DSPE (1.2:1molar
ratio) in deionized water at room temperature for 24 h. The
conjugation was puriﬁed by HPLC using an appropriate 0–60%
acetonitrile gradient in 0.1% triﬂuoroacetic acid, supplemented
with 10 mg/ml of dihydroxy benzoic acid. The purity of
the resulting product was 95% or higher. Carbonyl cyanide
m-chlorophenyl hydrazone (CCCP, C9H5ClN4, CAS: 555-60-2),
bis-(1,3-dibutylbarbituric acid) trimethineoxonol [DiBAC4(3)],
propidium iodide (PI) and 1-(3-dimethylaminopropyl)-3-ethyl-
carbodiimide (EDC) were obtained from Sigma (St. Louis, MO,
USA). Carboxyl near-infrared quantum dots (QDs605) were
purchased from Jiayuan QD Tech Ins (Wuhan, China).
Microorganisms
In this study, a total of 17 clinical isolates of K. pneumoniae were
used for the antimicrobial assay. These isolates were collected
between February and May 2013 in the Center of Medical
Laboratory of Zhongda Hospital (Southeast University, China).
The VITEK2 system with AST-GN13 cards and GN/CE strips
(bio Mérieux, Marcy l’Etoile, France) was used to conﬁrm the
identities and susceptibilities of bacteria. K. pneumonia ATCC
700603 from the Health Administrate of the People’s Republic of
China was used as a reference.
Animals
Adult male ICR mice (30–33 g) were obtained from the
Experimental Animal Center of Yangzhou, China and reared
in the Animal Environmental Control Unit under 23 ± 3◦C,
50 ± 10% relative humidity, and a 12-h light-dark cycle. The
animal experiments were carried out according to the guideline
from the Medical Ethics Committee of Southeast University,
China (Permit Number: 2013ZDSYLL109.0).
Preparation of the Liposomes and
Encapsulation Efficiency Measurement
The lipids formula, levoﬂoxacin dosage, ammonium sulfate
concentration, drug-loading temperature and time for liposome
preparation were optimized. HSPC, CHO, and Ts-PEG2000-
DSPE were mixed at diﬀerent ratio for the Ts-LPs liposome
preparation with the lipid ﬁlm hydration method. Levoﬂoxacin
was loaded into liposome with the ammonium sulfate gradient
method (see Supplementary Methods).
The liposome loaded levoﬂoxacin was measured by HPLC
to assess the optimization methods (Furneri et al., 2000)
(see Supplementary Methods). A standard curve was made
by measuring levoﬂoxacin standard concentration series
(Supplementary Figure S1). A solution containing 0-60%
gradient acetonitrile supplemented with 0.1% triﬂuoroacetic
acid was used as the mobile phase for HPLC. The injection
volume was ﬁxed to 20 µL. The results were assessed by the
encapsulation eﬃciency (EE), which was calculated as follows:
EE% = C1/C0∗100%, where C0 is the amount of total drug,
and C1 is the amount of drug entrapped in the liposomes.
Levoﬂoxacin-loaded liposome without TS (LEV-LPs) was
prepared in a similar way.
Liposome Properties
The liposome size, zeta potential, and polydispersity index (PDI)
of the liposome emulsion were measured using a Zetasizer Nano
ZS system (Malvern Instruments Ltd, Worcestershire, UK).
The shape and size were also examined by transmission
electron microscopy (TEM). The liposome suspension was
placed on copper grids with ﬁlms, stained with 2% (w/v)
phosphotungstic acid, air-dried for 10 min, and ﬁnally examined
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using a JEM-1010 transmission electron microscope (JEOL,
Tokyo, Japan) to determine the morphology of the liposome.
Antimicrobial Activity Assay
MICs were used to evaluate the antimicrobial activity of Ts,
levoﬂoxacin, LPs-LEV, Ts-LPs, and Ts-LPs-LEV, according to the
broth microdilution guidelines from the Clinical and Laboratory
Standards Institute (CLSI) (Anonymous, 2001). LPs-LEV and
Ts-LPs-LEV liposome concentrations were calculated as the
levoﬂoxacin-containing concentrations which were measured
by a similar method as the EE assay. Ts-LPs concentration
was calculated as the Ts-containing concentration. The ﬁnal
concentration for Ts, free levoﬂoxacin, LPs-LEV or Ts-LPs-
LEV in the tested wells ranged from 2 to 256 µg/mL. After
incubation at 37◦C for 16–24 h, the bacterial culture optical
density (OD) value was measured using a microplate reader with
a wavelength of 630 nm (MRX, Dynex). MICs are deﬁned as the
lowest concentration where 100% bacterial growth inhibition was
reached. Each of the experiments was performed in triplicate. The
combination of Ts with conventional antibiotics such as silver
nitrate, ampicillin and kanamycin was tested for a synergistic
eﬀect (see Supplementary Methods).
Bacterial Targeting of Ts and Ts-LPs
The carboxyl near-infrared quantum dot QDs605 was used
to determine the bacterial targeting of Ts. QDs605 and Ts
(molar ratio: 1:10) were co-incubated in a solution containing
1 mg/ml EDC for linkage for 2 h at room temperature.
The prepared conjugate, Ts-QDs605 was rinsed twice with
PBS (0.1M, pH7.4) and stored at 4◦C before usage. The Ts-
functionalized liposome containing coumarin (Ts-LPs-CM) was
prepared using a similar method as described above. The cells
pretreated with Ts-QDs605 or Ts-LPs-CM were imaged using a
confocal microscope (Olympus, Japan) with excitation/emission
wavelengths of 470/505 nm for coumarin and 388/605 nm for
QDs605. The photographic parameters were chosen from default
and no changes for relative measurements.
Effects of Ts and Ts-LPs on Membrane
Permeability and Potential
A single colony of K. pneumonia ATCC 700603 was inoculated
in Luria-Bertani (LB) broth and cultured at 37◦C to reach log-
phase. A sample containing approximate 107 cells/ml medium
was prepared and added with 100 µg/ml Ts or Ts-LPs plus
10 mM CCCP (carbonyl cyanide m-chlorophenyl hydrazone,
C9H5ClN4, a type of respiratory inhibitor) followed by an
incubation at 37◦C for 60 min. PBS was used as a negative
control. The bacterial cells were retrieved and washed twice with
PBS (0.1M, pH7.4). The lipophilic anionic membrane potential-
sensitive dye DiBAC4(3) or nucleic acid dye PI was added at
a ﬁnal concentration of 10 µg/ml and incubated for 10 min
at room temperature before ﬂow cytometric analysis by BD
FACS Canto (Becton Drive, NJ, USA). The excitation/emission
wavelengths were 470/510 nm and 488/630 nm for DiBAC4(3)
and PI, respectively. The photographic exposure time was set to
500 ms for all measurements.
TABLE 1 | Zeta potential versus Ts-PEG2000-DSPE dosage (w/w).
Clip CT Zeta potential
100% 0% −29.43 ± 1.32 mV
99% 1% +8.56 ± 2.43 mV
95% 5% +20.68 ± 1.72 mV
The liposome formula was optimized as shown in Supplementary Tables S1 and S2.
Ts-PEG2000-DSPE was incorporated into the formula at different concentrations to
produce positively charged liposomes. The Zeta potential increased along with the
concentration of Ts-PEG2000-DSPE in the liposome. At 5% (w/w) concentration,
the zeta potential reached +20.68 ± 1.72 mV. Clip represented the total weight
ratio of HSPC:cholesterol (CHO) (7:3) used in the liposome preparation, and CT
was the ratio of Ts-PEG2000-DSPE.
Electron Microscopy Studies of
K. pneumoniae Treated with Ts-LPs-LEV
Transmission electron microscopy (TEM) was employed to
conﬁrm the cellular morphological changes after Ts-LPs-LEV
treatment (Chapple et al., 1998). Cells were retrieved after
receiving saline or Ts-LPs-LEV, and slices were made from cell
pellets (see Supplementary Methods). The slices were pre-stained
with aqueous uranyl acetate and lead citrate before being sent for
examination with a JEM-1010 transmission electron microscope
(JEOL, Tokyo, Japan).
Drug Uptake
The accumulation of free levoﬂoxacin and levoﬂoxacin liposomes
(LPs-LEV) was determined as previously reported (Furneri et al.,
2000). The cellular levoﬂoxacin was retrieved by destruction of
the bacterial cells and measured by HPLC, as described for the
liposome EE assay. The extracellular levoﬂoxacin concentration
in the supernatant was measure by HPLC as well.
Septic Shock Model
Sixty male ICR mice were randomly grouped (15 animals in
each group), and intraperitoneally inoculated with 2.5 × 107
cells of clinical MDR isolate CI 130702215 of K. pneumonia
(MIC > 256 µg/mL for levoﬂoxacin, refer to Table 1).
Immediately after the bacterial challenge, the animals were
intravenously administrated with levoﬂoxacin, LPs-LEV or Ts-
LPs-LEV. Levoﬂoxacin in all forms were equal at the dosage of
levoﬂoxacin of 10 mg/kg. The survival rate was monitored and
FIGURE 1 | Schematic representation of the preparation of Ts-LPs-LEV.
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FIGURE 2 | Factors affecting the encapsulation efficiency (EE). The
drug-loading experiments were performed using the ammonium sulfate
gradient method. (A) Influence of ammonium sulfate on EE (settings: 60◦C,
30 min). (B) Influence of incubation temperature (settings: 0.2 mol/L
ammonium sulfate, 30 min incubation). (C) Influence of incubation time
(settings: 0.2 mol/L ammonium sulfate, 60◦C). Results indicated peak EE
values at 0.2 mol/L ammonium sulfate, 60◦C, and an incubation time of
20 min.
blood samples were taken by tail-vein puncture every 6 h for the
next 3 days.
Approximately 24 h after bacterial challenge, 0.5 mL
abdominal lavage ﬂuid was collected using a long needle through
TABLE 2 | Liposome properties by ZetasizerNano ZS system.
Liposome Diameter size (nm) PDI Zeta potential (mV)
LPs 161.3 ± 4.5 0.293 −29.43
Ts-LPs 151.1 ± 2.4 0.216 +20.68
Ts-LPs-LEV 152.5 ± 3.2 0.254 +5.3
A volume of 10 µL liposome sample mixed with 990 µL saline was placed in the
cuvette and equilibrated for 10 min before measurement at 25◦C. The result was
the mean value taken from three repeats for each measurement.
intraperitoneal puncture at 10 min after an intraperitoneal
injection of 2 mL sterile saline. Bacterial counting was
performed by spreading the samples onto blood agar plates
after series dilution of the samples in sterile saline. The
plates were incubated overnight at 37◦C for bacterial colony
counting.
Statistical Analysis
MICs are presented as the mean value from three
independent measurements. The quantitative evaluations
of levoﬂoxacin accumulation in bacteria and bacterial
counting in the intra-abdominal ﬂuid and blood cultures
are expressed as the means ± standard deviations
(SDs). The analysis of variance (ANOVA) was used for
comparison between groups. The mortality rate diﬀerences
between groups were compared using Fisher’s exact test.
In all the analyses, P < 0.05 was considered statistical
signiﬁcant.
RESULTS
Preparation and Characterization of the
Liposomes
The prepared liposome consisted of HSPC, CHO, and Ts-
PEG2000-DSPE, with Ts anchored on the surface. The scheme for
the preparation of Ts-LP-LEV is showed in Figure 1. As shown
in Table 1, Supplementary Tables S1 and S2 and Figure 2, the
liposome preparation of Ts-LPs-LEV was optimized as follows:
(1) Formula: 30 mg/ml HSPC:CHO (4:1, w/w) plus 5% Ts-
PEG2000-DSPE; (2) levoﬂoxacin:lipids = 1:4 (mol/mol); (3)
drug loading parameters: using 0.2 mol/L ammonium sulfate,
incubation at 60◦C for 20 min. The drug loading eﬃciency EE%
reached 76.8 ± 2.7% after optimization. As shown in Table 2
and Figure 3, the prepared Ts-LEV-LPs with a PDI of 0.254
were 152.5 ± 3.2 nm in diameter showing a good homogeneity,
and were positively charged as expected. The blank liposome
without levoﬂoxacin was +20.68 mV in zeta potential. The
Ts-LPs-LEV possessed a zeta potential of +4.6–5.9 mV. The
positive charge indicated the presence of the positively charged
Ts on the surface. The liposomes were conﬁrmed of a spherical
shape with a diameter of ∼86.9 nm by TEM (Figure 3). The
TEM showed decreased size because the TEM imaging was
performed in a high-vacuum environment causing liposome
shrinkage. The prepared liposomes showed a very good stability
in aqueous buﬀer. No apparent changes or degradation were
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FIGURE 3 | Size distribution and transmission electron microscopy (TEM) image of Ts-LPs-LEV.
observed after the liposomes were stored for 2 months (data not
shown).
Confocal Laser Scanning Microscopy
(CLSM)
Ts was labeled with the near-infrared quantum dots to conﬁrm
the bacterial uptake of Ts. Bacteria were co-incubated with Ts-
QDs605 for 60 min before being sent for microscope. The
CLSM results indicated that bacteria received Ts-QDs605 gave
out stronger ﬂuorescence than that of bacteria receiving QDs605
(Figures 4A,B). The uptake of Ts-LPs in the bacteria was
also assessed by CLSM using coumarin (CM)-loaded liposome.
As shown in Figures 4C,D, Ts-LPs-CM treated bacterial cells
exhibited higher ﬂuorescence intensity than in the LP-CM treated
cells.
Effects of Ts and Ts-LPs on Membrane
Permeability and Potential by Flow
Cytometric Determination
Flow cytometry was employed to investigate the eﬀects of
Ts and Ts-LPs on the membrane permeability and potential.
The results of the bacteria exposed to PI or DiBAC4(3)
were shown in Figure 5. After adding Ts or Ts-LPs, the
cell percentages of the dye-associated ﬂuorescence signiﬁcantly
increased (P < 0.01). Bactericidal kinetics experiment indicated
Ts and Ts-LPs had a rapid bactericidal eﬀect and killed
99% bacteria within the ﬁrst 10 min (Supplementary Figure
S2). The CCCP with a capacity of reducing energization
and respiration in cells dramatically decreased Ts- or Ts-LPs-
induced uptake of PI (P < 0.05) and DiBAC4(3) (P < 0.01;
Figures 5A,B).
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FIGURE 4 | Ts-QDs605 and Ts-LPs-CM selectively targeting Klebsiella pneumoniae cells. The cell-targeting of Ts to K. pneumoniae ATCC 700603 observed
by confocal laser scanning microscopy (CLSM) using quantum dots (QD) or coumarin (CM)-loaded liposomes (LPs): (A) QDs605. (B) Ts-QDs605. (C) LPs-CM.
(D) Ts-LPs-CM. K. pneumonia ATCC 700603 cells (approximately 1 × 105 bacteria/ml) were first incubated with Ts-QDs605 (10 nM) for 2 h at 37◦C followed by trice
rinse with PBS, and then placed on slides. A solution containing 4% (wt/vol) paraformaldehyde was added for sample fixation for 30 min. Ts-LPs-CM were used at
20 nM but different from Ts-QDs605 assay, the cells receiving Ts-LPs-CM were sent to CLSM without washing with PBS. The bar indicated scale of 5 µm.
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FIGURE 5 | Ts and Ts-LPs affecting membrane permeability of
K. pneumoniae ATCC 700603. Bacteria incubated with Ts or Ts-LPs-LEV
following by staining with (A) PI or (B) DiBAC4(3). The error bars represent SD
(n = 5).
FIGURE 6 | Intra-bacterial levofloxacin accumulation of levofloxacin in
K. pneumoniae ATCC 700603. Error bars represent the standard deviation
of three measurements.
Bacteria Uptake of Levofloxacin
HPLC was used to measure the intracellular levoﬂoxacin
level. The levoﬂoxacin accumulation in diﬀerent groups was
presented in Figure 6. A gradual uptake of levoﬂoxacin
following a rapid accumulation was observed in the LPs-
LEV and Ts-LPs-LEV treated groups. No apparent uptake
was observed after 10 min (data not shown), and Ts and its
conjugates killed 99% bacteria within 10 min by CFU counting
assay (Supplementary Figure S2). A signiﬁcant diﬀerence was
observed between the Ts-LPs-LEV and LPs-LEV groups with
intracellular concentrations of 657 ± 47 and 500 ± 52 ng/mg
protein, respectively (P < 0.05). Compared with the free
drug group (150 ± 35 ng/mg protein), levoﬂoxacin in
liposome formulations reached signiﬁcantly higher intracellular
accumulations (P < 0.001).
In Vitro Antimicrobial Activities Against
Clinical MDR-isolates
All 17 K. pneumoniae clinical isolates were multi-drug-resistant,
and their MICs to levoﬂoxacin ranged from 8 to >256 µg/mL.
Their in vitro susceptibilities to Ts, free levoﬂoxacin, LPs-
LEV and Ts-LPs-LEV were listed in Table 3. The application
of liposome as a drug carrier greatly improved the eﬃcacy
of levoﬂoxacin, and incorporation of Ts again improved the
eﬃcacy of the LPs-LEV liposome. The MICs of the LPs-
LEV and Ts-LPs-LEV were 1-2- and 2-16-dilution lower than
that of the free drug, respectively. Drug-free Ts-LPs showed a
decreased eﬃcacy compared to Ts. No antimicrobial activity
was observed in the blank liposome (data not shown). Ts
showed at least additive eﬀects when in combination with the
conventional antimicrobial agents. Levoﬂoxacin in combination
with 0.2X MIC of Ts reached a synergistic eﬀect (Supplementary
Table S3).
The Bactericidal Effect by Transmission
Electron Microscope
Log-phase bacterial cells were exposed to the liposome for 1 h to
characterize the antimicrobial eﬀect of Ts-LPs-LEV. Remarkable
changes were observed with electron microscope (Figure 7)
such as chaotic membranemorphology, vacuolization, chromatin
concentration, and cell debris that was similar to the eﬀects of Ts
as we reported before.
In Vivo Antimicrobial Activities
A septic shock model was established by intraperitoneal injection
of MDR clinical isolate and treatment with the free drug, LPs-
LEV or Ts-LPs-LEV, respectively. The lethality rate at 24 h was
100% in both the saline-treated group and free levoﬂoxacin-
treated group, whereas it was 73.3 or 6.7% for the LPs-LEV-
treated group or for the Ts-LPs-LEV-treated group, respectively.
All the animals from the LPs-LEV-treated group were deadwithin
36 h, whereas 93.3% of the animals from the Ts-LPs-LEV-treated
group survived at 72 h (Figure 8).
The bacterial culture results were showed in Table 4. At 24 h,
all animals were positive for bacterial culture of the blood and
peritoneal ﬂuid samples, but colony count in the groups treated
with LPs-LEV and Ts-LPs-LEV was signiﬁcantly less than that
of the saline and levoﬂoxacin treated groups (P < 0.05). The
Ts-LPs-LEV showed an improved eﬃcacy on bacteria clearance
compared to LPs-LEV (P < 0.05). To our surprise, levoﬂoxacin
used alone showed none priority over saline to bacterial clearance
(P > 0.2).
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FIGURE 7 | Bactericidal effect of Ts-LPs-LEV. Electron micrographs of K. pneumoniae ATCC 700603 incubated for 1 h after receiving (A) saline or
(B) Ts-LPs-LEV. The length of the scale bar in the TEM image is 200 nm.
DISCUSSION
The designed liposome Ts-LPs was stable and met multiple
requirements for a drug carrier. The liposome properties were
closely aﬀected by lipid species and their composition. CHO is
the most comprehensive example. CHO comprises up to 50% of
the total lipids of mammal cell membrane but rarely present in
bacterial cells. CHO renders the lipid bilayer ﬂexibility as well
as stability. Incorporation of CHO into liposome formula can
reduce unfavorable liposomal leakage and prohibit membrane
fusion in artiﬁcial systems (Shimanouchi et al., 2009). Charge
on the liposome surface prevents self-contact and self-fusion
improving the stability of the liposome. A proper charge on the
liposome surface introduced by Ts was another guarantee that the
produced liposome remained stable for at least 2 months, and
allowed the electrostatic attraction between the liposomes with
negatively charged components from the bacterial membrane.
The incorporation of DSPE and HSPC was meant to stabilize
the liposome and to mediate the fusion of the liposome
with bacterial membranes (Ma et al., 2010). PEGylation is a
mature technique and has been widely applied in pharmaceutical
industry. PEGylation reduced non-speciﬁc interactions between
drugs with proteins and cells, and thus decreases the drug
degradation and prolongs the drug circulation in the bloodstream
(Anonymous, 2007). The drugmetabolism and pharmacokinetics
of the liposomes would be an interesting topic for the next step.
Levoﬂoxacin was loaded to the liposomes using the
ammonium sulfate gradient method (Haran et al., 1993)
and reached a high EE. The carrier capacity is an important
parameter to evaluate a drug delivery system for eﬀective
antibacterial chemotherapy. The ammonium sulfate gradient
method has several advantages, including a shorter preparation
period, milder conditions and higher drug EE than those of
other methods (Fritze et al., 2006). Our results demonstrated
that the levoﬂoxacin EE (%) of Ts-LPs-LEV was ∼76% using
the ammonium sulfate gradient method, which was higher than
that of the reverse phase evaporation method, ethanol injection
method, or citric acid gradient method (data not shown).
Ts and levoﬂoxacin combination against K. pneumoniae
showed at least additive eﬀects and it reached synergism when
levoﬂoxacin was used in combination with 0.2X MIC of Ts
(Supplementary Table S3). Similarly, the antimicrobial activity
assay demonstrated that the MICs of Ts-LPs-LEV against 17
K. pneumoniae clinical isolates were 2–16-fold lower than
that of the free drug (Table 3). This was consistent with the
drug uptake results, and was attributed to the distinguishing
mechanism of action between Ts and Levoﬂoxacin that we would
discussed later. It was reasonable that Ts showed decreased
activity when it was immobilized onto the liposome because
such immobilization reduced the ﬂexibility and geometrically
prohibited the interaction between Ts monomers which was
called self-promoting interaction during the unique membrane
intercalation process of AMPs (Prado Montes de Oca, 2013).
Diﬀerent K. pneumoniae strains varied in susceptibility to Ts.
It may be due to the modiﬁcation at the cell envelope of wild
type bacteria after receiving antibiotic treatment, particularly
the LPS and/or negatively charged content. The selectivity of
AMPs is largely dependent on the electrostatic interaction. Such
a modiﬁcation on the charge content at the cell envelope altered
the susceptibility of the bacteria to Ts. However, the measurement
of cellular charge of bacterial cells seemed infeasible. We tried
several times but got totally diﬀerent results for diﬀerent cultures
from the same colony. A pure study in artiﬁcial systems such as
the liposome suggested the correlationship between charge and
AMP eﬃciency (Prado Montes de Oca, 2013).
The bacterial uptake of coumarin (CM)-loaded Ts-LPs-CM
was imaged by CLSM (Dong and Feng, 2007; Ma et al.,
2010). The result was similar to that observed in the drug
uptake assay by HPLC. The drug uptake assay revealed that
the liposome delivery system was very eﬀective. The liposome
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FIGURE 8 | Mortality data reported as Kaplan–Meier curves for
levofloxacin formulations in a septic shock model induced by a
multidrug resistant (MDR) clinical isolate. After bacterial challenge by
injection of 2.5x107 CFU of the multidrug-resistant clinical isolate
K. pneumoniae CI 130702215, the animals were immediately injected in their
tail veins with sterile saline, free levofloxacin, LPs-LEV or Ts-LPs-LEV. The
survival rate was monitored every 6 h for 3 days without any intervention
except for the experimental drugs.
TABLE 4 | Bacterial clearance and mouse survival in septic shock models.
Treatment Lethality
[dead/total
(%)]
Bacterial count in
blood
(CFU/mL)
Bacterial count in
peritoneal fluid
(CFU/mL)
Saline 15/15 (100) 5.1 ± 2.0 × 106 7.8 ± 3.1 × 107
Free LEV 15/15 (100) 4.7 ± 1.5 × 106 6.3 ± 2.5 × 107
LPs-LEV 11/15 (73.3) 2.7 ± 1.1 × 103∗ 2.2 ± 1.0 × 104∗
Ts-LPs-LEV 1/15 (6.7)∗# 1.4 ± 0.4 × 101∗# 5.6 ± 1.3 × 101∗#
The samples were collected at 24 h or immediately after the dead mouse was
observed. Mice were observed every 6 h. Error is represented as the standard
deviation (n = 15). ∗P < 0.05 vs. the saline or the free LEV groups. #P < 0.05 vs.
the LPs-LEV group.
beneﬁted the drug uptake by bacteria, and Ts could improve
such eﬀect resulting into relative higher uptake by bacteria
for Ts-LPs-LEV/Ts-LPs-CM. Theoretically, Ts-LPs would result
into a more promising eﬀect if it was used in vivo where
Ts-LPs could distinguish mammal cells from bacteria while
the liposome without Ts might be distracted by mammal
cells. In view of our previous study, highly positively charged
Ts could selectively target bacterial cells through electrostatic
interaction with negatively charged components present on the
outer bacterial membranes, i.e., saccharide moieties of various
natures, phospholipids, glycosphingolipids, peptidoglycan, and
in particular the LPS that was proved to show aﬃnity with Ts by
ELISA assay (Wu et al., 2010b). By contrast, Ts showed a very
limited cytotoxicity on mammal cells (Wu et al., 2010b).
The HPLC might not be a proper method to determine
the cellular drug uptake. The Ts intercalated into the cellular
membrane linking/fusing the liposomes with the cells. So it is
impossible to separate the Ts-LPs from the cells by centrifugation
or dialysis. Therefore, the HPLC measured the drug both inside
the cells and in the surface adherent liposomes. We could
not determine whether the drug remained in the liposomes or
FIGURE 9 | Schematic representation of Ts-LPs-LEV killing bacteria
process. Briefly, when Ts-LPs-LEV co-incubated with the bacteria, Ts carried
a large amount of levofloxacin-loaded liposomes to the bacterial surface and
anchored in the outer membrane by combination with LPS and/or negatively
charged components. Then, the liposomes fused with the bacterial cell outer
membrane, which could enhance levofloxacin entry through hydrophobic
and/or self-promoted pathway or contact release. Meanwhile, Ts perturbed
the membrane lipid bilayers of the bacteria and removed the electrical
potential of the membrane, affecting the activity of the drug efflux pumps and
thus resulting in an intra-bacterial levofloxacin accumulation. The cells finally
became dead and broken.
entered into the cells. However, fusion or linkage between the
liposomes and the cellular membrane would greatly facilitate
the drug uptake by the bacterial cells, and the drug would
later enter into the cells by membrane fusion. The size of
the liposome is about 100 nm while the cell is about 500–
2000 nm. The CLSM image did not provide information about
cellular location of the liposomes due to the limited resolution.
It was hard to tell whether the liposomes entered inside or
still remained at the surface. The subcellular structures of the
cells are visible under electronic microscope but the electronic
microscopy lacks discernment between the liposomes and cells.
An image indicating the cellular location of the liposomes would
be helpful to understand more details.
The in vivo test using mouse model after bacterial challenge
indicated the multiple functions of Ts in the liposome complex.
Bacterial challenge would ﬁrst evoke a systematic inﬂammation
and ﬁnally developed a multiple organ failure that killed the
mice. Antibiotics treatment is not prioritized for septic patients.
The serious inﬂammation induced by endotoxin/exotoxin is
highly concerned. From the results, the merits of using Ts were
very convincible. Ts resulted into a better bacterial clearance
in peritoneal ﬂuid and blood compared with free levoﬂoxacin
and LPs-LEV (P < 0.05; Table 2), and greatly improved the
survival rate probably through prohibiting the LPS-mediated
inﬂammation.
It has been suggested that transport across the gram
negative bacterial cell wall might be achieved by three diﬀerent
ways, namely, hydrophilic transport through porin channels
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(Nikaido and Vaara, 1985), hydrophobic adsorption through the
lipid membrane (Kotera et al., 1991) and self-promoted uptake
(Chapman and Georgopapadakou, 1988). Drug properties such
as the hydrophobicity, size and molecular structure can aﬀect
the hydrophilic and hydrophobic pathway. The self-promoted
uptake route is based on the displacement of divalent cations
from the LPSs on the bacterial outer membrane.
It is well known that the non-speciﬁc drug eﬄux and low outer
membrane permeability are the major mechanisms for bacterial
resistance to ﬂuoroquinolone antibiotics (Nikaido and Vaara,
1985; Srikumar et al., 1998; Srinivasan et al., 2014). The ﬂow
cytometry results suggested that the membrane permeability of
bacteria was increased by the addition of Ts or Ts-LPs. These
ﬁndings indicated that Ts killed bacteria at least partially by
exhausting the transmembrane potential that is closely related to
the bacterial respiration and energization.
Our results are consistent with the following proposed
mechanism of TS-LPs-LEV action : (1) Ts led levoﬂoxacin-
loaded liposomes to the bacterial surface by interacting with
negatively charged content on the bacterial envelop such as LPS;
(2) liposomes fused with the bacterial cell outer membrane, which
could enhance drug entry through the hydrophobic and/or self-
promoted pathway; (3) the integrity of the bacterial cytoplasmic
membrane and the respiration chain located on the cytoplasmic
membrane was compromised due to Ts insertion resulting into
more drug uptake and active eﬄux failure; and (4) liposomes gave
a contact release of levoﬂoxacin (Furneri et al., 2000) close to the
bacterial cell surface, resulting in a higher drug uptake than the
free drug (Figure 9).
In summary, we successfully developed an antimicrobial-
peptide-functionalized levoﬂoxacin-loaded liposome (Ts-LPs-
LEV). The liposome showed bacterial selectivity in vitro and
exhibited an excellent therapeutic eﬀect in the septic mouse
model induced by MDR K. pneumoniae clinic isolate. We
presented a very promising approach to design a novel
antibiotics deliver of targeting potential. The clinical application
of this promising antibiotic delivery approach deserves further
exploration.
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